OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5

olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
$1.3751per EA

Strength

10; 12.5; 40 mg/1; mg/1; mg/1

NDC

70436001704

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210718

On Market Since

5/15/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+9.4%

3M

-1.5%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.